Notices. Notice; withdrawal
229 words·~1 min read·
/register/2005/02/24/05-3596A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
BILLING CODE 4160-01-S DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. 2003D-0386] Agency Emergency Processing Under the Office of Management and Budget Review; Draft Guidance for Industry on Formal Dispute Resolution: Scientific and Technical Issues Related to Pharmaceutical Current Good Manufacturing Practice; Withdrawal AGENCY: Food and Drug Administration, HHS. ACTION: Notice; withdrawal. SUMMARY: The Food and Drug Administration
(FDA)is withdrawing a notice that published in the **Federal Register** on January 26, 2005 (70 FR 3712). DATES: This notice is withdrawn on February 24, 2005. FOR FURTHER INFORMATION CONTACT: Karen L. Nelson, Office of Management Programs (HFA-250), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-1482. SUPPLEMENTARY INFORMATION: In the **Federal Register** of January 26, 2005, FDA published a notice informing interested parties that the proposed collection of information entitled “Draft Guidance for Industry on Formal Dispute Resolution: Scientific and Technical Issues Related to Pharmaceutical Current Good Manufacturing Practice” had been submitted to the Office of Management and Budget
(OMB)for processing in compliance with (44 U.S.C. 3507(j), of the Paperwork Reduction Act of 1995 and 5 CFR 1320.13). The notice contains a number of errors. Therefore, we are withdrawing both the notice itself and the request for OMB approval of the proposed collection of information. Dated: February 17, 2005. Jeffrey Shuren, Assistant Commissioner for Policy. [FR Doc. 05-3596 Filed 2-23-05; 8:45 am]
Connectionstraces to 1
Traces to 1 document
1 reference not yet in our index
- 5 CFR 1320.13
Citation graph
cites case law
Cites 2Cited by 0 across 0 sources